Del Rosso James Q, Cash Kimberly
Dr. Del Rosso is Adjunct Clinical Professor (Dermatology), Touro University College of Oseopathic Medicine, Henderson, Nevada, and is with the has Vegas Skin and Cancer Clinics/West Dermatology Group, Las Vegas, Nevada. Dr. Cash is Scientific Affairs Consultant, North Carolina.
J Clin Aesthet Dermatol. 2013 Nov;6(11):20-7.
Topical corticosteroids are a very important part of the treatment of many skin disorders, especially eczematous dermatoses. When utilized properly and judiciously these agents often achieve excellent results in clearing or markedly improving many dermatological disorders. As some studies have shown, topical corticosteroids, despite their ability to decrease inflammation through several mechanisms, induce abnormalities in lipid synthesis and intercellular bilayer structure in the stratum corneum, which appear to prolong epidermal barrier recovery. These adverse effects may contribute to eariier eczematous flaring if measures to provide barrier repair are not undertaken. In addition, although topical corticosteroids are applied only to sites affected by the skin eruption, the incorporation of "barrier friendly" excipients into the vehicle that improve stratum corneum permeability barrier function and integrity is very rational.
外用皮质类固醇是许多皮肤疾病治疗中非常重要的一部分,尤其是湿疹性皮炎。如果合理谨慎使用,这些药物在清除或显著改善许多皮肤病方面常常能取得优异效果。正如一些研究所示,外用皮质类固醇尽管能够通过多种机制减轻炎症,但会导致角质层脂质合成和细胞间双层结构异常,这似乎会延长表皮屏障的恢复时间。如果不采取措施进行屏障修复,这些不良反应可能会导致湿疹更早复发。此外,虽然外用皮质类固醇仅应用于皮疹受累部位,但在载体中加入“屏障友好型”辅料以改善角质层渗透屏障功能和完整性是非常合理的。